Stevens-Johnson syndrome after treatment with azithromycin: an uncommon culprit

Thomas M Nappe; Stephanie L Goren-Garcia; Jeanne L Jacoby

doi:10.1016/j.ajem.2015.06.039

Stevens-Johnson syndrome after treatment with azithromycin: an uncommon culprit

Am J Emerg Med. 2016 Mar;34(3):676.e1-3. doi: 10.1016/j.ajem.2015.06.039. Epub 2015 Jun 19.

Authors

Thomas M Nappe¹, Stephanie L Goren-Garcia², Jeanne L Jacoby²

Affiliations

¹ Department of Emergency Medicine, Lehigh Valley Hospital/USF Morsani College of Medicine, Allentown, PA. Electronic address: tom.nappe@gmail.com.
² Department of Emergency Medicine, Lehigh Valley Hospital/USF Morsani College of Medicine, Allentown, PA.

PMID: 26194400
DOI: 10.1016/j.ajem.2015.06.039

Abstract

Azithromycin is a commonly prescribed antibiotic but is not considered a common etiologic agent for Stevens-Johnson syndrome (SJS). SJS is a dermatologic emergency that occurs within a spectrum of severity and can result in severe morbidity and mortality.

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / adverse effects*
Azithromycin / adverse effects*
Diagnosis, Differential
Emergencies
Humans
Male
Middle Aged
Stevens-Johnson Syndrome / diagnosis
Stevens-Johnson Syndrome / etiology*

Substances

Anti-Bacterial Agents
Azithromycin